Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1208863
Max Phase: Preclinical
Molecular Formula: C18H12Cl2N2O
Molecular Weight: 343.21
Molecule Type: Small molecule
Associated Items:
ID: ALA1208863
Max Phase: Preclinical
Molecular Formula: C18H12Cl2N2O
Molecular Weight: 343.21
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(N/N=C/c1ccc(Cl)c(Cl)c1)c1ccc2ccccc2c1
Standard InChI: InChI=1S/C18H12Cl2N2O/c19-16-8-5-12(9-17(16)20)11-21-22-18(23)15-7-6-13-3-1-2-4-14(13)10-15/h1-11H,(H,22,23)/b21-11+
Standard InChI Key: TXMVXGSSJXHCGB-SRZZPIQSSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 343.21 | Molecular Weight (Monoisotopic): 342.0327 | AlogP: 4.91 | #Rotatable Bonds: 3 |
Polar Surface Area: 41.46 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.67 | CX Basic pKa: 1.00 | CX LogP: 5.16 | CX LogD: 5.16 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.53 | Np Likeness Score: -1.67 |
1. Lee S, Jung KY, Park J, Cho JH, Kim YC, Chang S.. (2010) Synthesis of potent chemical inhibitors of dynamin GTPase., 20 (16): [PMID:20621477] [10.1016/j.bmcl.2010.06.092] |
Source(1):